MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: A tool for image-guided local drug delivery

Contrast Media and Molecular Imaging

Volumn 8, Issue 2, 2013, Pages 185-192

  Lorenzato, Cyril ^a,b   Cernicanu, Alexandru ^c   Meyre, Marie Edith ^d   Germain, Matthieu ^d   Pottier, Agnès ^d   Levy, Laurent ^d   de Senneville, Baudouin Denis ^b,e   Bos, Clemens ^b   Moonen, Chrit ^a,b   Smirnov, Pierre ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UMR 5287   (France)

^c PHILIPS HEALTHCARE   (United States)

^d NANOBIOTIX   (France)

^e UNIVERSITÉ BORDEAUX 1   (France)

Author keywords

Local drug delivery; MRI; Thermosensitive liposomes; Ultrasound

Indexed keywords

LIPOSOME; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; THERMOSENSITIVE MAGNETOLIPOSOME; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HEAT SENSITIVITY; HEATING; HIGH INTENSITY FOCUSED ULTRASOUND; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE TRANSITION; PRIORITY JOURNAL; TEMPERATURE;

CONTRAST MEDIA; DELAYED-ACTION PREPARATIONS; HOT TEMPERATURE; LIPOSOMES; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MATERIALS TESTING; SONICATION; SOUND;

EID: 84871652577     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1515     Document Type: Article

References (40)

1. Lake RA, Robinson BWS. Immunotherapy and chemotherapy - a practical partnership. Nat Rev Cancer 2005; 5: 397-405; doi: 10.1038/nrc1613
2. Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, Hagerty KL, Somerfield MR, Vaughn DJ. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 2007; 25: 3991-4008; doi: 10.1200/JCO.2007.10.9777
3. Alaouie AM, Sofou S. Liposomes with triggered content release for cancer therapy. J Biomed Nanotech 2008; 4: 234-244; doi: 10.1166/jbn.2008.335
4. Allen TM, Cullis PR. Drug delivery systems: entering the mainstream. Sci 2004; 303: 1818-1822; doi: 10.1126/science.1095833
5. Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Rel 2008; 126: 187-204; doi: 10.1016/j.jconrel.2007.12.017
6. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63: 136-151; doi: 10.1016/j.addr.2010.04.009
7. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238-252; doi: 10.1016/S0022-2836(65)80093-6
8. Bangham AD. Surrogate cells or Trojan horses. The discovery of liposomes. Bioessays 1995;17:1081-1088; doi: 10.1002/bies.950171213
9. Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prot Lip Res 2005; 44: 68-97; doi: 10.1016/j.plipres.2004.12.001
10. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7: 771-782; doi: 10.1038/nrd2614
11. Batist G, Ramakrishnan G, Rao CS, Chandrasekharan A, Gutheil J, Guthrie T, Shah P, Khojasteh A, Nair MK, Hoelzer K, Tkaczuk K, Park YC, Lee LW. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol 2001;19:1444-1454.
12. Yatvin M, Weinstein J, Dennis W, Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 1978; 202: 1290-1293;doi: 10.1126/science.364652
13. Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med 2009; 60: 417-430; doi: 10.1146/annurev.med.60.041707.170303
14. Staruch R, Chopra R, Hynynen K. Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hypertherm 2011; 27: 156-171; doi: 10.3109/02656736.2010.518198
15. Ranjan A, Jacobs GC, Woods DL, Negussie AH, Partanen A, Yarmolenko PS, Gacchina CE, Sharma KV, Frenkel V, Wood BJ, Dreher MR. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Rel 2012; 158: 487-494; doi: 10.1016/j.jconrel.2011.12.011
16. Deckers R, Moonen CTW. Ultrasound triggered, image guided, local drug delivery. J Control Rel 2010; 148: 25-33; doi: 10.1016/j.jconrel.2010.07.117
17. 1: Methods and preliminary results of application to drug delivery using thermosensitive liposomes. Magn Reson Med 2005; 54: 1020-1024; doi: 10.1002/mrm.20635
18. de Smet M, Langereis S, den Bosch S van Grüll H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Rel 2010; 143: 120-127; doi: 10.1016/j.jconrel.2009.12.002
19. Terreno E, Delli Castelli D, Cabella C, Dastrù W, Sanino A, Stancanello J, Tei L, Aime S. Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications. Chem Biodivers 2008; 5: 1901-1912; doi: 10.1002/cbdv.200890178
20. Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res 2009; 42: 822-831; doi: 10.1021/ar800192p
21. Smirnov P, Gazeau F, Beloeil J-C, Doan BT, Wilhelm C, Gillet B. Single-cell detection by gradient echo 9.4T MRI: a parametric study. Contrast Media Mol Imag 2006; 1: 165-174; doi: 10.1002/cmmi.104
22. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 2003; 49: 646-654; doi: 10.1002/mrm.10418
23. Smirnov P. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy. Metab Mol Biol 2009; 512: 333-353; doi: 10.1007/978-1-60327-530-9_19
24. Bulte JW, De Cuyper M. Magnetoliposomes as contrast agents. Meth Enzymol 2003;373:175-198.
25. Bulte JWM, de Cuyper M, Despres D, Frank JA. Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent. J Magn Magn Mater 1999; 194: 204-209; doi: 10.1016/S0304-8853(98)00556-3
26. Bouchet AM, Lairion F, Ruysschaert J-M, Lensink MF. Oligoarginine vectors for intracellular delivery: Role of arginine side-chain orientation in chain length-dependent destabilization of lipid membranes. Chem Phys Lip 2012; 165: 89-96; doi: 10.1016/j.chemphyslip.2011.11.008
27. 2 MR contrast agent based on heparinized superparamagnetic iron oxide nanoparticles. Macromol Res 2011; 19: 843-847; doi: 10.1007/s13233-011-0805-0
28. de Haan HW. Mechanisms of proton spin dephasing in a system of magnetic particles. Magn Reson Med 2011; 66: 1748-1758; doi: 10.1002/mrm.22966
29. Demas V, Lowery TJ. Magnetic resonance for in vitro medical diagnostics: superparamagnetic nanoparticle-based magnetic relaxation switches. New J Phys 2011; 13: 025005; doi: 10.1088/1367-2630/13/2/025005
30. 2-shortening by weakly magnetized particles: The chemical exchange model. Magn Reson Med 2001; 45: 1014-1020; doi: 10.1002/mrm.1135
31. 2-Shortening by strongly magnetized spheres: a chemical exchange model. Magn Reson Med 2002; 47: 388-391; doi: 10.1002/mrm.10064
32. 2* relaxation rate resulting from the encapsulation of magnetic particles with hydrophilic coatings. Magn Reson Med 2011; 66: 1759-1766; doi: 10.1002/mrm.22944
33. Lasic D. Liposomes: from Physics to Applications. Elsevier: Amsterdam, 1993.
34. Hecht AM, Geissler E. Dynamic light scattering from polyacrylamide-water gels. J Phys 1978; 39: 631-638; doi: 10.1051/jphys:01978003906063100
35. Bacri J-C, Perzynski R, Salin D, Cabuil V, Massart R. Ionic ferrofluids: a crossing of chemistry and physics. J Magn Magn Mater 1990; 85: 27-32; doi: 10.1016/0304-8853(90)90010-N
36. Yoshimura K, Waki H, Ohashi S. Ion-exchanger colorimetry-I: micro determination of chromium, iron, copper and cobalt in water. Talanta 1976; 23: 449-454; doi: 10.1016/0039-9140(76)80126-9
37. Martina M-S, Fortin J-P, Ménager C, Clément O, Barratt G, Grabielle-Madelmont C, Gazeau F, Cabuil V, Lesieur S. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. J Am Chem Soc 2005; 127: 10676-10685; doi: 10.1021/ja0516460
38. Michel N, Fabiano A-S, Polidori A, Jack R, Pucci B. Determination of phase transition temperatures of lipids by light scattering. Chem Phys Lipids 2006; 139: 11-19; doi: 10.1016/j.chemphyslip.2005.09.003
39. Quesson B, de Zwart JA, Moonen CTW. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imag 2000; 12: 525-533; doi: 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V
40. Rieke V, Butts Pauly K. MR thermometry. J Magn Reson Imag 2008; 27: 376-390; doi: 10.1002/jmri.21265